GCT1184-02: A Phase 3 Randomized, Open-Label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator s Choice in Patients with Platinum Resistant Ovarian Cancer
- Title
- A Phase 3 Randomized, Open-Label Study of Rinatabart Sesutecan (Rina-S) versus Treatment of Investigator s Choice in Patients with Platinum Resistant Ovarian Cancer
- Principal Investigator
- Pfaendler, Krista
- Phase
- III
- Age Group
- Adult
- Applicable Disease Sites
- Gynecologic Cancers
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu